Obstetrics & Gynecology Doctors in St Clair Shores, MI Accepting Medicare

8 Obstetrics & Gynecology doctors found. Showing 1 - 8

Ann R Mcreynolds, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 21000 E 12 Mile Rd, 102, St Clair Shores, MI 48081 Phone: 586-447-5100    Fax: 586-447-5090

Nathan S. White, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 21000 E 12 Mile Rd, St Clair Shores, MI 48081 Phone: 586-447-5100    Fax: 586-447-5090

Manuela B O'campo, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 21000 E 12 Mile Rd, 102, St Clair Shores, MI 48081 Phone: 810-447-5700    Fax: 810-447-5010

Dr. Constantine Raphtis, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 19714 E 10 Mile Rd, St Clair Shores, MI 48080 Phone: 586-779-9400    Fax: 586-779-8949

Jennifer Kuzel, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 21000 E 12 Mile Rd, 102, St Clair Shores, MI 48081 Phone: 586-447-5100    Fax: 586-447-5090

Veena B Chari Hedni, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 21000 E 12 Mile Rd, 102, St Clair Shores, MI 48081 Phone: 586-447-5100    Fax: 586-447-5090

Dr. Graciano Figueras Singson, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 19714 E 10 Mile Rd, St Clair Shores, MI 48080 Phone: 586-779-9400    Fax: 586-779-8949

Dr. Kami Michele Kveton, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 19714 E 10 Mile Rd, St Clair Shores, MI 48080 Phone: 586-779-9400    Fax: 586-779-8949

News Archive

MR-guided focused ultrasound may effectively control essential tremor

In a presentation at the Congress of Neurological Surgeons today, University of Virginia neurosurgeon W. Jeffrey Elias, MD reported that preliminary results of a pilot clinical trial indicate that MR-guided focused ultrasound has the potential to safely and effectively control essential tremor (ET), a common neurological condition that affects 10 million Americans.

EnteroMedics to submit an IDE application for next-generation Maestro RC System

EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity and other gastrointestinal disorders, announced today that, following a recent meeting with the U.S. Food and Drug Administration (FDA) to discuss the Company's EMPOWER™ study results and the regulatory process, the Company intends to submit an Investigational Device Exemption (IDE) application for a clinical trial to support a possible Premarket Approval (PMA) application for the next-generation Maestro® RC System in the treatment of morbid obesity.

Sense accelerates launch of new SARS-CoV-2 disposable test

Sense Biodetection Limited has today announced an accelerated programme to launch the world's first instrument-free, point-of-care molecular diagnostic test for SARS-CoV-2, the coronavirus responsible for the COVID-19 pandemic.

Physical-distancing slows spread of COVID-19 and reduces ICU admissions

The world is now at a standstill, as many countries have imposed restrictions to stem the spread of the coronavirus disease (COVID-19). Nations are in lockdowns indefinitely, until the situation improves. The vast spread of the novel coronavirus is now inevitable, as the number of confirmed cases topped 1.85 million, many scientists are determining health measures that could help mitigate the global pandemic.

Intellipharmaceutics receives purchase agreement commitments for $12,000,000

Intellipharmaceutics International Inc. today announced that it has received purchase agreement commitments from institutional investors to provide the Company with approximately US$12,000,000 in gross proceeds through the sale of its common stock and warrants.

Read more Medical News

› Verified 3 days ago